Nimble Therapeutics Appoints Shelley Allen As Head of Drug Discovery and Munir Mosaheb As Head of Biology

Apr 03, 2024•over 1 year ago

Position

Head Of Biology

Company

Nimble Therapeutics

Munir Mosaheb

MadisonTherapeuticsBiotechnology

Description

Nimble Therapeutics announced the opening of a second R&D site in Philadelphia, PA, focusing on progressing their pipeline of orally-delivered peptide therapeutics. In addition, the company appointed Shelley Allen as Head of Drug Discovery and Munir Mosaheb as Head of Biology to spearhead the drug discovery efforts and catalyze the build out of the Philadelphia site and team.

Company Information

Company

Nimble Therapeutics

Location

500 South Rosa Road

Madison, Wisconsin, United States

About

Nimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months